Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

211.68B

Market cap211.68B

Price-Earnings ratio

11.12

Price-Earnings ratio11.12

Dividend yield

2.60%

Dividend yield2.60%

Average volume

13.02M

Average volume13.02M

High today

$48.04

High today$48.04

Low today

$47.39

Low today$47.39

Open price

$47.82

Open price$47.82

Volume

2.83M

Volume2.83M

52 Week high

$71.80

52 Week high$71.80

52 Week low

$35.12

52 Week low$35.12

NVO News

The Motley Fool 9h

The Artificial Intelligence Opportunity Beyond Big Tech: 3 Healthcare Stocks to Watch

Investors looking to capitalize on the rapidly growing artificial intelligence (AI) industry tend to turn toward leading tech corporations. That's understandabl...

Bloomberg 20h

Novo Says Twice as Many Medicare Patients Prefer GLP-1 Pill - Bloomberg

...

Simply Wall St 1d

Novo Nordisk Stock After Recent Pharma Sector Focus Is The Valuation Attractive

If you are wondering whether Novo Nordisk stock is starting to look attractively priced or still carries a premium, the current setup offers plenty of clues in...

Analyst ratings

54%

of 37 ratings

Buy

37.8%

Hold

54.1%

Sell

8.1%

More NVO News

TipRanks 1d

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

24/7 Wall St. 2d

Forget Novo Nordisk. Pfizer's Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Pfizer didn't make the cut. Grab the names FREE today . Novo Nordisk's US...

Nasdaq 2d

NVO Gains as Foundation Unveils EUR 60M Cardiometabolic Research Push

Novo Nordisk NVO shares gained 6.2% on Monday after the Novo Nordisk Foundation, the controlling shareholder of the Danish drugmaker, unveiled a major pan-Europ...

Nasdaq 3d

Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk

Key Points Viking Therapeutics has a weight-loss program that looks to be competitive with medicines already on the market. It's unclear how its candidate com...

Benzinga 3d

Novo Nordisk Stock Is Surging Monday: What's Driving The Action?

Novo Nordisk stock is showing exceptional strength. Why is NVO stock surging? What Is Driving Novo Nordisk’s Stock Rally? Novo Nordisk’s rally is landing in a m...

Simply Wall St 5d

Novo Nordisk Faces Cyber Breach While Pushing Oral Wegovy Into China

Novo Nordisk (NYSE:NVO) reported a material cybersecurity breach involving stolen patient, clinical, and proprietary data that attackers are seeking to monetize...

Simply Wall St 5d

Why Hims & Hers Health Is Up 32.3% After Novo Nordisk GLP-1 Deal And Telehealth Push

In recent weeks, Hims & Hers Health has secured a partnership with Novo Nordisk to offer GLP-1 weight-loss drugs, completed the acquisition of digital health pl...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.